Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04354701

COVID-19 and Cancer Consortium Registry

The COVID-19 and Cancer Consortium (CCC19) Registry

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
19,275 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In this study we will collect granular information on cancer patients infected with COVID-19, as rapidly as possible. The mechanism for collection of this information is a de-identified centralized registry housed at Vanderbilt University Medical Center, with data donations from internal and external health care professionals.

Detailed description

The COVID-19 and Cancer Consortium (CCC19) registry prospectively collects anonymized data about patients diagnosed with COVID-19 and cancer. The goal of the registry is to generate hypothesis-generating and hypothesis-supporting findings that are generalizable to the population at large. Specifically: I. Characterize patient factors, such as pre-existing comorbidities, baseline medication exposures, cancer type, status, and treatment, and demographic factors that are associated with short- and long-term outcomes of COVID-19 (laboratory-confirmed or presumptive), including severity and fatality, in patients with cancer. II. Describe cancer treatment modifications made in response to COVID-19, including dose adjustments, changes in symptom management, or temporary or permanent cessation. III. Evaluate the association of COVID-19 with cancer outcomes.

Conditions

Interventions

TypeNameDescription
OTHERWeb-based REDCap surveyThe survey takes approximately 5-10 minutes to complete and includes five parts: 1) basic demographics about the patient, including performance status and comorbidities; 2) initial COVID-19 diagnosis and clinical course; 3) cancer and cancer treatment details; 4) respondent details; 5) long-term COVID-19 outcomes.

Timeline

Start date
2020-03-17
Primary completion
2028-12-01
Completion
2029-12-01
First posted
2020-04-21
Last updated
2024-01-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04354701. Inclusion in this directory is not an endorsement.